Resultados de procura - Rob E. Aarnoutse

Limitar resultados
  1. 1
    Implications of the global increase of diabetes for tuberculosis control and patient care

    Implications of the global increase of diabetes for tuberculosis control and patient care por Rovina Ruslami, Rob E. Aarnoutse, Bachti Alisjahbana, André van der Ven, Reinout van Crevel

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development

    New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development por Jossy van den Boogaard, Gibson Kibiki, Elton R. Kisanga, Martin J. Boeree, Rob E. Aarnoutse

    Publicado 2008
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study

    Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study por Jossy van den Boogaard, Ramsey A. Lyimo, Martin J. Boeree, Gibson Kibiki, Rob E. Aarnoutse

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Evaluation of Antiretroviral Drug Measurements by an Interlaboratory Quality Control Program

    Evaluation of Antiretroviral Drug Measurements by an Interlaboratory Quality Control Program por J. A. H. Droste, Rob E. Aarnoutse, Peter P. Koopmans, Yechiel A. Hekster, David M. Burger

    Publicado 2003
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Pharmacokinetics and Tolerability of a Higher Rifampin Dose versus the Standard Dose in Pulmonary Tuberculosis Patients

    Pharmacokinetics and Tolerability of a Higher Rifampin Dose versus the Standard Dose in Pulmonary Tuberculosis Patients por Rovina Ruslami, Hanneke M. J. Nijland, Bachti Alisjahbana, Ida Parwati, Reinout van Crevel, Rob E. Aarnoutse

    Publicado 2007
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Cost Evaluation of Dried Blood Spot Home Sampling as Compared to Conventional Sampling for Therapeutic Drug Monitoring in Children

    Cost Evaluation of Dried Blood Spot Home Sampling as Compared to Conventional Sampling for Therapeutic Drug Monitoring in Children por Lisa C. Martial, Rob E. Aarnoutse, Michiel F. Schreuder, Stefanie Henriet, Roger J. M. Brüggemann, Manuela Joore

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Pharmacokinetics of First-Line Tuberculosis Drugs in Tanzanian Patients

    Pharmacokinetics of First-Line Tuberculosis Drugs in Tanzanian Patients por Alma Tostmann, Charles Mtabho, Hadija Semvua, Jossy van den Boogaard, Gibson Kibiki, Martin J. Boeree, Rob E. Aarnoutse

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Antituberculosis drug‐induced hepatotoxicity: Concise up‐to‐date review

    Antituberculosis drug‐induced hepatotoxicity: Concise up‐to‐date review por Alma Tostmann, Martin J. Boeree, Rob E. Aarnoutse, Wiel C.M. de Lange, André van der Ven, Richard Dekhuijzen

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  9. 9
    Intensified antibiotic treatment of tuberculosis meningitis

    Intensified antibiotic treatment of tuberculosis meningitis por Fiona V Cresswell, Lindsey te Brake, Rachel Atherton, Rovina Ruslami, Kelly E. Dooley, Rob E. Aarnoutse, Reinout van Crevel

    Publicado 2018
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  10. 10
    Isoniazid, Rifampin, and Pyrazinamide Plasma Concentrations in Relation to Treatment Response in Indonesian Pulmonary Tuberculosis Patients

    Isoniazid, Rifampin, and Pyrazinamide Plasma Concentrations in Relation to Treatment Response in Indonesian Pulmonary Tuberculosis Patients por Erlina Burhan, Carolien Ruesen, Rovina Ruslami, Arum Ginanjar, Hadiarto Mangunnegoro, Purwantyastuti Ascobat, Rogier Donders, Reinout van Crevel, Rob E. Aarnoutse

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Rifampicin Reduces Plasma Concentrations of Moxifloxacin in Patients with Tuberculosis

    Rifampicin Reduces Plasma Concentrations of Moxifloxacin in Patients with Tuberculosis por Hanneke M. J. Nijland, Rovina Ruslami, A. J. Suroto, David M. Burger, Bachti Alisjahbana, Reinout van Crevel, Rob E. Aarnoutse

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses

    A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses por Robin J. Svensson, Rob E. Aarnoutse, Andreas H. Diacon, Rodney Dawson, Stephen H. Gillespie, Martin J. Boeree, Ulrika S. H. Simonsson

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Pharmacokinetics of Antituberculosis Drugs in Pulmonary Tuberculosis Patients with Type 2 Diabetes

    Pharmacokinetics of Antituberculosis Drugs in Pulmonary Tuberculosis Patients with Type 2 Diabetes por Rovina Ruslami, Hanneke M. J. Nijland, I. Gusti N. Adhiarta, S.H.K.S. Kariadi, Bachti Alisjahbana, Rob E. Aarnoutse, Reinout van Crevel

    Publicado 2009
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Pharmacogenetics and Pharmacokinetics of Moxifloxacin in MDR-TB Patients in Indonesia: Analysis for ABCB1 and SLCO1B1

    Pharmacogenetics and Pharmacokinetics of Moxifloxacin in MDR-TB Patients in Indonesia: Analysis for ABCB1 and SLCO1B1 por Nurul Annisa, Nadiya Nurul Afifah, Prayudi Santoso, Vycke Yunivita, Lindsey H. M. te Brake, Rob E. Aarnoutse, Melisa Intan Barliana, Rovina Ruslami

    Publicado 2025
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Pharmacokinetics of Moxifloxacin in Cerebrospinal Fluid and Plasma in Patients with Tuberculous Meningitis

    Pharmacokinetics of Moxifloxacin in Cerebrospinal Fluid and Plasma in Patients with Tuberculous Meningitis por Jan‐Willem C. Alffenaar, Richard van Altena, H. J. Bökkerink, Gert Jan Luijckx, Dick van Soolingen, Rob E. Aarnoutse, Tjip S. van der Werf

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Model-Based Meta-analysis of Rifampicin Exposure and Mortality in Indonesian Tuberculous Meningitis Trials

    Model-Based Meta-analysis of Rifampicin Exposure and Mortality in Indonesian Tuberculous Meningitis Trials por Elin M. Svensson, Sofiati Dian, Lindsey te Brake, Ahmad Rizal Ganiem, Vycke Yunivita, Arjan van Laarhoven, Reinout van Crevel, Rovina Ruslami, Rob E. Aarnoutse

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  17. 17
    Engaging community pharmacy in tuberculosis case detection (ENHANCE): a study protocol for an implementation study in Indonesia

    Engaging community pharmacy in tuberculosis case detection (ENHANCE): a study protocol for an implementation study in Indonesia por Ivan Surya Pradipta, Carla Florencia, Cut Ainul Mardhiyyah, Firda Shafira Nurfadila, Kevin Aprilio, Rizky Abdulah, Bony Wiem Lestari, Rovina Ruslami, Trisasi Lestari, Rob E. Aarnoutse

    Publicado 2025
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial Simulations

    Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial Simulations por Robin J. Svensson, Elin M. Svensson, Rob E. Aarnoutse, Andreas H. Diacon, Rodney Dawson, Stephen H. Gillespie, Vineshree Mischka Moodley, Martin J. Boeree, Ulrika S. H. Simonsson

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP

    Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP por Vincent J. Lempers, Jeroen J. M. W. van den Heuvel, Frans G. M. Rüssel, Rob E. Aarnoutse, David M. Burger, Roger J. M. Brüggemann, Jan J. Koenderink

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience

    Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience por Arianna D. Pranger, Richard van Altena, Rob E. Aarnoutse, Dick van Soolingen, D. R. A. Uges, Jos G.W. Kosterink, Tjip S. van der Werf, Jan‐Willem C. Alffenaar

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: